A Comparison of the Effects of Low- And High-Dose Atorvastatin on Lipoprotein Metabolism and Inflammatory Cytokines in Type II Diabetes: Results From the Protection Against Nephropathy in Diabetes With Atorvastatin (PANDA) Randomized Trial
Journal of Clinical Lipidology - Netherlands
doi 10.1016/j.jacl.2017.10.011
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2018
Authors
Publisher
Elsevier BV